ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Net Receivables history
Currency unavailable · from the balance sheet
No Net Receivables data reported for this period type.
Net Receivables vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $22.22M USD | +31.9% | +199.6% | 19.3% | |
| Mar 2026 | $17.96M USD | +243.7% | -14.3% | 7.3% | |
| Mar 2026 | $15M USD | — | — | 5.1% | |
| Mar 2026 | $6.14M USD | +913.4% | +137.8% | 1.4% | |
| Mar 2026 | €2.72M EUR | -8.7% | -55.1% | 2.7% | |
| Mar 2026 | $1.34M USD | -90.8% | +26.3% | 0.5% | |
| Mar 2026 | $3K USD | +0.0% | +122.4% | 0.0% | |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | +0.0% | +74.3% | 1.4% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.